alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma

Area of Science:

• Genetics
• Hepatology
• Oncology

Background:

• Alpha-1-antitrypsin (AAT) deficiency (homozygous Pi ZZ) is linked to cirrhosis and hepatocellular carcinoma (HCC).
• The association between heterozygous Pi Z state and HCC remains unclear.
• Understanding AAT variant roles is crucial for HCC risk stratification.

Purpose of the Study:

• To investigate the phenotypic distribution of alpha-1-antitrypsin (Pi) variants in HCC patients.
• To determine if heterozygous Pi Z state is associated with an increased risk of HCC.
• To explore associations between specific AAT phenotypes and HCC subtypes.

Main Methods:

• Phenotypic analysis of alpha-1-antitrypsin (Pi) variants in 124 HCC cases.
• Comparison with 2010 normal American Red Cross blood donors as controls.
• Detailed clinical data collection, including cirrhosis etiology and HCC subtype.

Main Results:

• Aberrant Pi phenotypes were observed in 9.67% of HCC patients versus 8.36% in controls.
• The incidence of the Z gene (MZ phenotype) was similar in HCC patients (4.0%) and controls (2.9%).
• Three of five MZ patients had fibrolamellar HCC; MF phenotype occurred only in HCC patients.

Conclusions:

• No significant increase in the Z gene incidence was found in HCC patients compared to the general population.
• The heterozygous Pi Z state does not appear to be a significant risk factor for HCC.
• Further research may explore the role of other aberrant AAT phenotypes, like MF, in specific HCC subtypes.